2014 Biology of Acute Respiratory Infection Gordon Research Conference and Semina
2014 Biology of Acute Respiratory Infection Gordon Research Conference and Semina
批准号:
8650427
负责人:
LESTER KOBZIK
金额:
$0.7万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2014-05-31
关键词:
AIDS/HIV problemAcuteAcute respiratory infectionAreaBacteriaBiologyCessation of lifeCollaborationsDataDevelopmentDisabled PersonsEpidemiologyFosteringFundingGoalsHost DefenseHumanImmuneImmune responseImmunologicsImmunologistImmunologyInfectionItalyLeadLeisure ActivitiesLungMalignant NeoplasmsMedicalModelingMorbidity - disease rateNatural ImmunityOrganismOutcomePathogenesisPathologyPostdoctoral FellowPreventionPrevention strategyPublic HealthReagentRequest for ApplicationsResearchResearch PersonnelRespiratory Tract InfectionsRunningScheduleScienceScientistSignal TransductionStagingSystems BiologyTechnologyThinkingTranslatingUnderrepresented MinorityVirusWomanWorkadaptive immunitycareerdisorder preventionexperiencefungusgraduate studentimprovedinsightinterestmeetingsmicrobialmortalitynext generationnovelnovel strategiespathogenpeerposterspublic health relevanceresponsesymposiumvaccine development
中文摘要
描述(由申请人提供):本申请申请资金部分支持戈登急性呼吸道感染生物学研究会议第四次会议。本次会议将于2014年2月23日至28日在意大利伊乔科举行,我们预计将有110 - 150名科学家参加。这次多学科会议的首要目标是提供一个环境来展示和讨论急性肺部感染领域的杰出研究。由于感染肺部的各种病原体激活了有限数量的保守免疫反应,因此在不同病原体领域工作的同事和研究不同病原体的同事之间可以共享大量信息。发病机制的一般原理、先天免疫和局部免疫保护激活背后的系统生物学与许多不同类型的肺部感染高度相关。会议将持续4天半,每天上午的演讲涉及与不同类型肺部感染相关的先天免疫的一般主题。专门讨论跨学科主题和特定病原体的会议将在上午和晚上举行,每次会议都由经验丰富的讨论主持人主持,这些主持人通常是在以前的会议上介绍过自己工作的科学家。主题将包括肺部感染机制的新进展,宿主和病原体相互作用的组学方法的见解,新的先天免疫细胞和信号,桥接先天和适应性反应,合并感染及其发病机制,以及转化实验科学以改善床边结果的进展。下午晚些时候的海报会议将提供一个非正式的场所来讨论正在进行的工作,并使研究生和博士后能够与他们感兴趣的领域的各种名人以及他们的同龄人见面。之前的戈登研究研讨会将吸引和受益研究生和学员。在邀请演讲者和招募与会者的各个阶段,我们将努力鼓励妇女、代表性不足的少数民族和残疾人参与。由于肺部感染是美国和世界范围内死亡的主要原因,本次会议与公共卫生高度相关,并将潜在地促进疾病预防和疫苗开发的新方法。
英文摘要
DESCRIPTION (provided by applicant): This application requests funding to partially support the fourth meeting of the Gordon Research Conference on the Biology of Acute Respiratory Infection. This meeting will be held in Il Ciocco, Italy February 23-28 2014, and we expect 110 - 150 scientists to participate. The overarching goal of this multi-disciplinary conference is to provide a setting to present and discuss outstanding research in the area of acute lung infection. As the diverse pathogens that infect the lung activate a limited number of conserved immunologic responses, there is a great deal of information that can be shared by colleagues working in and by colleagues who study different pathogens. General principles of pathogenesis, innate immunity and the systems biology behind activation of local immune protection are highly relevant to many different types of pulmonary infection. The meeting will run for 4 1/2 days leading off with presentations each morning dealing with general topics in innate immunity relevant to diverse types of lung infection. Sessions devoted to cross-disciplinary topics and specific pathogens will be held in morning and evening sessions, each led by an experienced discussion leader, often a scientist who has presented their own work at previous meetings. Topics will include new developments in mechanisms of lung infections, insights from 'omics approaches to host and pathogen interaction, novel innate immune cells and signals, bridging innate and adaptive responses, co-infections and their pathogenesis, and advances in translating bench science to improve bedside outcomes. Late afternoon poster sessions will provide an informal venue to discuss work-in progress and enable graduate students and post-docs to meet with various luminaries in their field of interest as well as their peers. A preceding Gordon Research Seminar will attract and benefit graduate students and trainees. At all stages of speaker invitation and recruitment of attendees we will strive to encourage participation by women, underrepresented minorities and people with disabilities. As pulmonary infection is a leading cause of mortality in the USA and worldwide this conference is highly relevant to public health and will potentially foster novel approaches to disease prevention and vaccine development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plasma Gelsolin as Immunotherapeutic for Antibiotic-Resistant Pneumonia
-
批准号:9146035
-
项目类别:
-
资助金额:$93.94万
-
财政年份:2016
-
负责人:LESTER KOBZIK
-
依托单位:
Plasma Gelsolin as Immunotherapeutic for Antibiotic-Resistant Pneumonia
-
批准号:9275351
-
项目类别:
-
资助金额:$97.08万
-
财政年份:2016
-
负责人:LESTER KOBZIK
-
依托单位:
Transgenerational Susceptibility to Asthma from Air Pollution Exposure
-
批准号:8598612
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2013
-
负责人:LESTER KOBZIK
-
依托单位:
Plasma Gelsolin and Host Defense After Lung Injury
-
批准号:8446681
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2013
-
负责人:LESTER KOBZIK
-
依托单位:
Plasma Gelsolin and Host Defense After Lung Injury
-
批准号:8989922
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2013
-
负责人:LESTER KOBZIK
-
依托单位:
Transgenerational Susceptibility to Asthma from Air Pollution Exposure
-
批准号:8728858
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2013
-
负责人:LESTER KOBZIK
-
依托单位:
RNAi Screen in Air Pollutant-Enhanced Influenza Infection
-
批准号:8272707
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2011
-
负责人:LESTER KOBZIK
-
依托单位:
RNAi Screen in Air Pollutant-Enhanced Influenza Infection
-
批准号:8130454
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2011
-
负责人:LESTER KOBZIK
-
依托单位:
Qiagen 96-Sample Pyrosequencer
-
批准号:7794497
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2010
-
负责人:LESTER KOBZIK
-
依托单位:
Prenatal Programming of Neonatal Asthma Susceptibility
-
批准号:7750741
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS
-
批准号:8515507
-
项目类别:
-
资助金额:$54.88万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS
-
批准号:7918168
-
项目类别:
-
资助金额:$58.64万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS
-
批准号:7714034
-
项目类别:
-
资助金额:$61.99万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS
-
批准号:8304970
-
项目类别:
-
资助金额:$58.35万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
Prenatal Programming of Neonatal Asthma Susceptibility
-
批准号:8450883
-
项目类别:
-
资助金额:$34.57万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
Prenatal Programming of Neonatal Asthma Susceptibility
-
批准号:8049139
-
项目类别:
-
资助金额:$72.64万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
Prenatal Programming of Neonatal Asthma Susceptibility
-
批准号:8249078
-
项目类别:
-
资助金额:$52.01万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS
-
批准号:8109219
-
项目类别:
-
资助金额:$60.03万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
Prenatal Programming of Neonatal Asthma Susceptibility
-
批准号:8037873
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2009
-
负责人:LESTER KOBZIK
-
依托单位:
Gender and Host Defense Against Pneumonia
-
批准号:7177473
-
项目类别:
-
资助金额:$39.81万
-
财政年份:2006
-
负责人:LESTER KOBZIK
-
依托单位:
海外基金